GlaxoSmithKline | Валовая Прибыль



Gross Profit On Sales Изменить Дата
AbbVie USD 10.71B 458M 2024-12
Alcon AG USD 1.38B 2M 2025-03
Almirall EUR 377.39M 145.71M 2024-12
Amgen USD 5.54B 430M 2025-03
argenx SE USD 709.88M 44.12M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Bayer EUR 8.11B 2.11B 2025-03
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Fresenius EUR 1.41B 4M 2025-03
Fresenius Medical Care EUR 1.18B 86.43M 2025-03
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 673M 5.43B 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Glaxosmithkline GBP 5.6B 94M 2024-12
GRIFOLS EUR 694.67M 71.83M 2025-03
Hikma Pharmaceutical USD 756M 82M 2024-06
Lonza CHF 1.12B 276M 2024-06
Merck EUR 3.1B 45M 2024-12
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Novo Nordisk 65.2B 5.19B 2025-03
Orion EUR 201.8M 65.5M 2025-03
Pfizer USD 11.12B 987M 2025-03
Philips EUR 1.85B 114M 2025-03
Recordati EUR 458.77M 73.65M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Smith & Nephew USD 2.07B 98M 2024-12
UCB EUR 970M 788M 2024-06



GlaxoSmithKline Валовая Прибыль - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.